Early research (Phase 1)Not Yet RecruitingNCT07579208
What this trial is testing
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
Who this might be right for
Phase 1NK CellIL13Ra+4 more
M.D. Anderson Cancer Center 36